The total return over the past 12 months is -32.41% vs. +16.94% for the S&P 500. So far it's up -1.32% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (32.41%) | (27.27%) | (33.38%) | (36.28%) | (27.01%) | (20.68%) |
| Total Return CAGR | (32.41%) | (27.27%) | (33.38%) | (36.28%) | (27.01%) | (20.68%) |
| Revenue CAGR | (21.12%) | (2.88%) | +2.59% | +2.24% | +1.67% | +4.97% |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (42.62%) | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | (17.16%) | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Rockwell Medical, Inc. (RMTI)
| Year | Start price | End price | RMTI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $8.34 | $8.23 | (1.32%) | +14.51% | (15.83%) |
| 2025 | $20.40 | $8.34 | (59.12%) | +17.72% | (76.84%) |
| 2024 | $18.90 | $20.40 | +7.94% | +24.89% | (16.95%) |
| 2023 | $10.10 | $18.90 | +87.13% | +26.19% | +60.94% |
| 2022 | $45.10 | $10.10 | (77.61%) | (18.17%) | (59.44%) |
| 2021 | $111.10 | $45.10 | (59.41%) | +28.74% | (88.15%) |
| 2020 | $268.40 | $111.10 | (58.61%) | +18.37% | (76.98%) |
| 2019 | $248.60 | $268.40 | +7.96% | +31.22% | (23.26%) |
| 2018 | $640.20 | $248.60 | (61.17%) | (4.56%) | (56.61%) |
| 2017 | $720.50 | $640.20 | (11.15%) | +21.70% | (32.85%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
